DNA damage, Mitomycin, cell senescence
19. Pospelova TV, Demidenko ZN, Bukreeva EI, Pospelov
VA, Gudkov AV, Blagosklonny MV. Pseudo-DNA damage response in senescent cells. Cell Cycle 2009; 8:4112-8; PMID:19946210; doc.guandang.net.
20. Halicka HD, Zhao H, Li J, Traganos F, Zhang S, Lee
M, et al. Genome protective effect of metformin as revealed by reduced level of constitutive DNA dam-age signaling. Aging (Albany NY) 2011; 3:1028-38; PMID:22067284.
21. Burhans WC, Weinberger M. DNA replication stress,
genome instability and aging. Nucleic Acids Res 2007; 35:7545-56; PMID:18055498; doc.guandang.net.
22. Itahana K, Campisi J, Dimri GP. Methods to detect
biomarkers of cellular senescence: the senescence-associated beta-galactosidase assay. Methods Mol Biol 2007; 371:21-31; PMID:17634571; doc.guandang.net.
23. Cho S, Hwang ES. Fluorescence-based detec-tion and quantification of features of cellular senescence. Methods Cell Biol 2011; 103:149-88; PMID:21722803; doc.guandang.net.
24. Demidenko ZN, Korotchkina LG, Gudkov AV,
Blagosklonny MV. Paradoxical suppression of cel-lular senescence by p53. Proc Natl Acad Sci USA 2010; 107:9660-4; PMID:20457898; doc.guandang.net.
25. Zhao H, Halicka HD, Traganos F, Jorgensen E,
Darzynkiewicz Z. New biomarkers probing depth of cell senescence assessed by laser scanning cytometry. Cytometry A 2010; 77:999-1007; PMID:20939035; doc.guandang.net.
26. te Poele RH, Okorokov AL, Jardine L, Cummings J,
Joel SP. DNA damage is able to induce senescence in tumor cells in vitro and in vivo. Cancer Res 2002; 62:1876-83; PMID:11912168.
27. Schmitt CA, Fridman JS, Yang M, Lee S, Baranov E,
Hoffman RM, et al. A senescence program controlled by p53 and p16INK4a contributes to the outcome of can-cer therapy. Cell 2002; 109:335-46; PMID:12015983; doc.guandang.net(02)00734-1.28. Roberson RS, Kussick SJ, Vallieres E, Chen SYJ, Wu
DY. Escape from therapy-induced accelerated cel-lular senescence in p53-null lung cancer cells and in human lung cancers. Cancer Res 2005; 65:2795-803; PMID:15805280; doc.guandang.net.
29. Browder T, Butterfield CE, Kräling BM, Shi B,
Marshall B, O’Reilly MS, et al. Antiangiogenic sched-uling of chemotherapy improves efficacy against experimental drug-resistant cancer. Cancer Res 2000; 60:1878-86; PMID:10766175.
30. Klement G, Baruchel S, Rak J, Man S, Clark K,
Hicklin DJ, et al. Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sus-tained tumor regression without overt toxicity. J Clin Invest 2000; 105:R15-24; PMID:10772661; doc.guandang.net.
31. Demidenko ZN, Blagosklonny MV. Growth
stimulation leads to cellular senescence when the cell cycle is blocked. Cell Cycle 2008; 7:3355-61; PMID:18948731; doc.guandang.net.
32. Demidenko ZN, Zubova SG, Bukreeva EI, Pospelov
VA, Pospelova TV, Blagosklonny MV. Rapamycin decelerates cellular senescence. Cell Cycle 2009; 8:1888-95; PMID:19471117; doc.guandang.net.
33. Blagosklonny MV. Cell cycle arrest is not yet senes-cence, which is not just cell cycle arrest: terminology for TOR-driven aging. Aging (Albany NY) 2012; 4:159-65; PMID:22394614.
34. Korotchkina LG, Leontieva OV, Bukreeva EI,
Demidenko ZN, Gudkov AV, Blagosklonny MV. The choice between p53-induced senescence and quiescence is determined in part by the mTOR pathway. Aging (Albany NY) 2010; 2:344-52; PMID:20606252.
35. Selman C, Tullet JM, Wieser D, Irvine E, Lingard SJ,
Choudhury AI, et al. Ribosomal protein S6 kinase 1 signaling regulates mammalian lifespan. Science 2009; 326:140-4; PMID:19797661; doc.guandang.net.
36. Magnuson B, Ekim B, Fingar DC. Regulation and
function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks. Biochem J 2012; 441:1-21; PMID:22168436; doc.guandang.net.
37. Yin Z, Fan L, Huang G, Wang H, Wang Z. The possible
role of ribosomal protein S6 kinase 4 in the senescence of endothelial progenitor cells in diabetes mellitus. Cardiovasc Diabetol 2012; 11:12; PMID:22297070; doc.guandang.net.
38. Darzynkiewicz Z, Traganos F, Wlodkowic D. Impaired
DNA damage response--an Achilles’ heel sensitiz-ing cancer to chemotherapy and radiotherapy. Eur J Pharmacol 2009; 625:143-50; PMID:19836377; doc.guandang.net.
39. Demidenko ZN, McCubrey JA. Recent progress in
targeting cancer. Aging (Albany NY) 2011; 3:1154-62; PMID:22228887.
40. Omerovic J, Clague MJ, Prior IA. Phosphatome
profiling reveals PTPN2, PTPRJ and PTEN as potent negative regulators of PKB/Akt activation in Ras-mutated cancer cells. Biochem J 2010; 426:65-72; PMID:19922411; doc.guandang.net.
41. Brueckner B, Stresemann C, Kuner R, Mund C, Musch
T, Meister M, et al. The human let-7a-3 locus con-tains an epigenetically regulated microRNA gene with oncogenic function. Cancer Res 2007; 67:1419-23; PMID:17308078; doc.guandang.net.
42. Zhou Z, Hao Y, Liu N, Raptis L, Tsao MS, Yang X.
TAZ is a novel oncogene in non-small cell lung cancer. Oncogene 2011; 30:2181-6; PMID:21258416; doc.guandang.net.
43. Wang XQ, Li H, Van Putten V, Winn RA, Heasley
LE, Nemenoff RA. Oncogenic K-Ras regulates pro-liferation and cell junctions in lung epithelial cells through induction of cyclooxygenase-2 and activation of metalloproteinase-9. Mol Biol Cell 2009; 20:791-800; PMID:19037103; doc.guandang.net.
44. Buckley S, Shi W, Driscoll B, Ferrario A, Anderson
K, Warburton D. BMP4 signaling induces senescence and modulates the oncogenic phenotype of A549 lung adenocarcinoma cells. Am J Physiol Lung Cell Mol Physiol 2004; 286:L81-6; PMID:12959928; doc.guandang.net.
45. Darzynkiewicz Z, Bedner E, Li X, Gorczyca W,
Melamed MR. Laser-scanning cytometry: A new instrumentation with many applications. Exp Cell Res 1999; 249:1-12; PMID:10328948; doc.guandang.net.
46. Zhao H, Dobrucki J, Rybak P, Traganos F,
Darzynkiewicz Z. Relationship of DNA damage signal-ing induced by DNA topoisomerase inhibitors campto-thecin/topotecan, mitoxantrone or etoposide and DNA replication. Cytometry A 2012; 1012(81A):45-51.
3140 Cell Cycle Volume 11 Issue 16
热门文档